Success across the board for C4X Discovery Holdings plc and its partnerships
Drug discovery company C4X Discovery Holdings plc released a report today (August 2) detailing the continued…
August 2, 2022 - 3 minutes
Inflammatory disease
Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease
Enterome, a clinical stage biopharmaceutical company developing immunomodulatory drugs based on its bacterial Mimicry drug…
July 18, 2022 - 4 minutes
AI being used to perform molecular analysis of biopsies from bowel disease patients
Artificial intelligence will be used to perform molecular analysis of biopsies from unidentified Inflammatory Bowel…
July 12, 2022 - 2 minutes
Gemelli Biotech to work on gastrointestinal diseases with new $19M funding
U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed…
June 23, 2022 - 3 minutes
Upstream Bio to target asthma as it launches with $200M financing
Upstream Bio, a U.S. biotech company focused on inflammation, today exited stealth mode with $200M…
June 2, 2022 - 4 minutes
Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites
Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two…
May 27, 2022 - 3 minutes
OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B
The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll…
April 28, 2022 - 3 minutes
Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs
The UK-US venture capitalist Epidarex Capital has led an €11M (£9M) funding round raised by…
April 8, 2022 - 3 minutes
Targeted Drugs for Rare Autoimmune Disease Hit Regulatory Milestones
New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis,…
December 1, 2021 - 4 minutes
The Rollercoaster of Repurposing an Arthritis Drug for Covid-19
The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs…
May 10, 2021 - 8 minutes
Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
October 5, 2020 - 5 minutes
Roche Confirms Pharma Appetite for Inflammatory Disease Treatments
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…
September 25, 2020 - 4 minutes
